A detailed history of Verition Fund Management LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 6,511 shares of AMPH stock, worth $304,910. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,511
Holding current value
$304,910
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $251,650 - $283,098
6,511 New
6,511 $260,000
Q3 2023

Nov 14, 2023

BUY
$45.51 - $65.0 $138,896 - $198,380
3,052 Added 55.04%
8,597 $395,000
Q2 2023

Aug 14, 2023

BUY
$35.77 - $58.38 $198,344 - $323,717
5,545 New
5,545 $318,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.3B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.